Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Merck & Co
(NY:
MRK
)
112.52
+1.59 (+1.43%)
Official Closing Price
Updated: 7:00 PM EDT, Jun 2, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,792,840
Open
111.11
Bid (Size)
111.35 (1)
Ask (Size)
112.70 (5)
Prev. Close
110.93
Today's Range
110.72 - 112.73
52wk Range
83.05 - 119.65
Shares Outstanding
2,531,374,696
Dividend Yield
2.31%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Before Surgery and Continued as a Single Agent After Surgery Reduced the Risk of Event-Free Survival Events by 42% Versus Pre-Operative Chemotherapy in Resectable Stage II, IIIA or IIIB NSCLC
June 03, 2023
From
Merck & Co., Inc.
Via
Business Wire
KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Versus Chemotherapy Alone as First-Line Treatment for Unresectable Advanced Pleural Mesothelioma
June 03, 2023
From
Merck & Co., Inc.
Via
Business Wire
Performance
YTD
+1.24%
+1.24%
1 Month
-4.38%
-4.38%
3 Month
+1.28%
+1.28%
6 Month
+2.28%
+2.28%
1 Year
+25.24%
+25.24%
More News
Read More
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
June 02, 2023
Via
Investor's Business Daily
Analyst Ratings for Merck & Co
May 30, 2023
Via
Benzinga
BioNTech Surges On This Promising Update In Its Bid To Take On Bristol Myers In Lung Cancer Treatment
June 02, 2023
Via
Investor's Business Daily
3 Undervalued Dow Stocks to Buy Before Wall Street Does
June 02, 2023
Via
InvestorPlace
Medtronic, Merck, Williams Companies And More: CNBC's 'Final Trades'
June 01, 2023
Via
Benzinga
FDA Approves LYNPARZA® (olaparib) Plus Abiraterone and Prednisone or Prednisolone for Treatment of Adult Patients With BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC)
June 01, 2023
From
Merck & Co., Inc.
Via
Business Wire
Why PDS Biotech Shares Are Jumping Today
May 26, 2023
Via
Benzinga
Here's How Much You Would Have Made Owning Merck & Co Stock In The Last 5 Years
May 25, 2023
Via
Benzinga
7 Dividend Stocks to Buy (and Never Sell)
May 31, 2023
Via
InvestorPlace
3 Innovative Growth Stocks to Buy for Next-Gen Profits
May 31, 2023
Via
InvestorPlace
Rotation Out Of Healthcare And Biotech Stocks: Age Of Disruption?
May 30, 2023
Via
Talk Markets
Nvidia Becomes Ninth Company To Hit $1 Trillion Market Cap — Who Could Be Next To Join Elusive Club?
May 30, 2023
Via
Benzinga
Iovance Biotherapeutics Spikes on Melanoma BLA FDA Application
May 30, 2023
Via
MarketBeat
Topics
Death
Exposures
Death
Product Safety
Want to Grow Richer? These Stocks Have Doubled in the Past 5 Years
May 28, 2023
Via
The Motley Fool
Arcus Biosciences Soars On Roche's 'Meaningful' Results In A New Cancer Drug Class
May 26, 2023
Via
Investor's Business Daily
Amazon's Prime Video Trolls Netflix's Password Crackdown, Tesla Data Leak Exposes Safety Nightmare, Elon Musk's Brain Chip Company Gets FDA Nod For Human Trial: Top Stories For Today
May 26, 2023
Via
Benzinga
AstraZeneca/Merck's Cancer Drug Combo Shows Positive Results In Endometrial Cancer
May 26, 2023
Via
Benzinga
After Back To Back Failure For Keytruda Plus Lenvima, Merck Touts Durable Clinical Benefit For The Combo In Advanced Kidney Cancer
May 26, 2023
Via
Benzinga
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Long-Term, Durable Survival Benefit Versus Sunitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma
May 25, 2023
From
Merck & Co., Inc.
Via
Business Wire
7 Stocks That Could Be the Next $2 Trillion-Dollar Companies
May 23, 2023
Via
InvestorPlace
Merck Announces Third-Quarter 2023 Dividend
May 23, 2023
From
Merck & Co., Inc.
Via
Business Wire
Doximity is an Overlooked Medical Ecosystem AI Play
May 23, 2023
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
3 Undervalued Pharma Stocks to Buy for High Total Returns
May 19, 2023
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.